Physician perceptions and experience of current treatment in actinic keratosis

E. Stockfleth; Ketty Peris; C. Guillen; R. Cerio; N. Basset-Seguin; P. Foley; J. Sanches; A. Culshaw; S. Erntoft; M. Lebwohl

doi:10.1111/jdv.12530

Physician perceptions and experience of current treatment in actinic keratosis

E. Stockfleth
, Ketty Peris
, C. Guillen
, R. Cerio
, N. Basset-Seguin
, P. Foley
, J. Sanches
, A. Culshaw
, S. Erntoft
, M. Lebwohl

Charité – Universitätsmedizin Berlin
Instituto Valenciano de Oncologia
Barts Health NHS Trust
Université Paris Cité
University of Melbourne
Universidade de São Paulo
Adelphi Group
LEO Pharma AS
Icahn School of Medicine at Mount Sinai

Risultato della ricerca: Contributo in rivista › Articolo

20 Citazioni (Scopus)

Abstract

Topical therapy is important in the treatment of actinic keratosis (AK), a major risk factor for, and early development stage of, squamous cell carcinoma. Despite this, research addressing the limitations and challenges associated with topical field therapy in actinic keratosis is lacking.

Lingua originale	Inglese
pagine (da-a)	N/A-N/A
Rivista	Journal of the European Academy of Dermatology and Venereology
DOI	https://doi.org/10.1111/jdv.12530
Stato di pubblicazione	Pubblicato - 2014

Keywords

actinic keratosis

Accesso al documento

10.1111/jdv.12530

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

@article{7cf79fdb811446c286133a0fb9fd9ceb,

title = "Physician perceptions and experience of current treatment in actinic keratosis",

abstract = "Topical therapy is important in the treatment of actinic keratosis (AK), a major risk factor for, and early development stage of, squamous cell carcinoma. Despite this, research addressing the limitations and challenges associated with topical field therapy in actinic keratosis is lacking.",

keywords = "actinic keratosis, actinic keratosis",

author = "E. Stockfleth and Ketty Peris and C. Guillen and R. Cerio and N. Basset-Seguin and P. Foley and J. Sanches and A. Culshaw and S. Erntoft and M. Lebwohl",

year = "2014",

doi = "10.1111/jdv.12530",

language = "English",

pages = "N/A--N/A",

journal = "Journal of the European Academy of Dermatology and Venereology",

issn = "0926-9959",

publisher = "John Wiley and Sons Inc.",

}

TY - JOUR

T1 - Physician perceptions and experience of current treatment in actinic keratosis

AU - Stockfleth, E.

AU - Peris, Ketty

AU - Guillen, C.

AU - Cerio, R.

AU - Basset-Seguin, N.

AU - Foley, P.

AU - Sanches, J.

AU - Culshaw, A.

AU - Erntoft, S.

AU - Lebwohl, M.

PY - 2014

Y1 - 2014

N2 - Topical therapy is important in the treatment of actinic keratosis (AK), a major risk factor for, and early development stage of, squamous cell carcinoma. Despite this, research addressing the limitations and challenges associated with topical field therapy in actinic keratosis is lacking.

AB - Topical therapy is important in the treatment of actinic keratosis (AK), a major risk factor for, and early development stage of, squamous cell carcinoma. Despite this, research addressing the limitations and challenges associated with topical field therapy in actinic keratosis is lacking.

KW - actinic keratosis

UR - http://hdl.handle.net/10807/60927

U2 - 10.1111/jdv.12530

DO - 10.1111/jdv.12530

M3 - Article

SN - 0926-9959

SP - N/A-N/A

JO - Journal of the European Academy of Dermatology and Venereology

JF - Journal of the European Academy of Dermatology and Venereology

ER -

Physician perceptions and experience of current treatment in actinic keratosis

Abstract

Keywords

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo